Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Astrazeneca Plc ADR (NQ: AZN )

64.79 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Astrazeneca Plc ADR

< Previous 1 2
...
32 33 34 35 36 37 38 39 Next >
South Korea Negotiating With mRNA COVID-19 Vaccine Makers To Produce Up To 1B Doses: Reuters
South Korea is reportedly in talks with mRNA vaccine makers, including Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA), to produce COVID-19 shots in the... 
Via Benzinga
Exposures COVID-19
Tuesday Talk: Summer Stock
Summer is in full swing and as Q2 ends and its earning season begins it is time to take stock of 1H 2021 and see where things may be heading in 2H. 
Via Talk Markets
CytoSorbents Shares Are Trading Higher On Launch Of Trial On Ticagrelor Removal During Cardiothoracic Surgery
CytoSorbents Corporation (NASDAQ: CTSO) receives full FDA approval to conduct the STAR-T trial in the U.S. to support regulatory clearance of DrugSorb... 
Via Benzinga
Exposures Product Safety
Fireworks Display
The oil price rose to 76.81/bbl after the OPEC attempt to have a meeting to agree to boost production (and cut prices) was blocked. 
Via Talk Markets
All-Weather Portfolio: The Good, The Bad, And The Ugly
Healthcare, financials, and technology led the way in Q2. Energy, materials, industrials, and gold could have done better. 
Via Talk Markets
Why Coming in Second Could Be Great News for Pfizer and Moderna
And it could mean more bad news for AstraZeneca. 
Via The Motley Fool
Exposures COVID-19
Moderna ETFs To Rise On Positive COVID-19 Vaccine Updates
The competition to come up with a vaccine is opening up near-term opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide exposure to... 
Via Talk Markets
Exposures COVID-19
People Needed
If qualified people are not looking for work, they will have to be lured to do so with higher wages. 
Via Talk Markets
Exposures Labor
Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates
June was a month of plenty and also turned out to be a fruitful one from the perspective of Food and Drug Administration approvals. Regulatory reviews mostly produced positive... 
Via Benzinga
Moderna Stock Surges To Record High As Covid Battle Rages In India
Moderna stock surged to a record high Tuesday after its Covid vaccine protected against a handful of variants in an early-phase study. 
Via Investor's Business Daily
Exposures COVID-19
Moderna COVID-19 Vaccine Authorized For Emergency Use In India: What You Need To Know
Moderna, Inc.'s (NASDAQ: MRNA) COVID-19 vaccine should soon find its way into India, one of the countries worst affected by the second wave of the pandemic. What Happened:... 
Via Benzinga
Exposures COVID-19
Moderna's COVID-19 Vaccine Produced Neutralizing Titers Against All Variants Tested
Moderna Inc (NASDAQ: MRNA) has announced new results from in vitro neutralization studies of sera from individuals vaccinated with its COVID-19 vaccine. The COVID-... 
Via Benzinga
Exposures COVID-19
Why a Top European Official Is Warning to Avoid AstraZeneca's COVID Vaccine
The big drugmaker now faces another challenge for its COVID-19 vaccine. 
Via The Motley Fool
Exposures COVID-19
Saint Warren
Today the WTI oil price rose further up over 1%. 
Via Talk Markets
India Made AstraZeneca's COVID-19 Vaccine Not Eligible For EU Travel, Seeks Resolution: Reuters
Serum Institute of India's (SII) CEO Adar Poonawalla said he was trying to resolve EU travel problems facing Indians inoculated with SII's licensed version of... 
Via Benzinga
Exposures COVID-19
UK Study Of COVID-19 Shots Mix-Match Shows Immune Response, Can Add Flexibility To Vaccination Programs: CNBC
Mixing and matching the coronavirus vaccines made by Pfizer Inc (NYSE: PFE) - BioNTech SE (NASDAQ: BNTX) and AstraZeneca Plc (NASDAQ: AZN) - Oxford... 
Via Benzinga
Exposures COVID-19
AstraZeneca COVID-19 Vaccine Shows Higher Immune Response With Longer Gap, Third Booster Dose
A sub-analysis from the Oxford-led COV001 and COV002 trials with AstraZeneca Plc (NASDAQ: AZN) COVID-19 vaccine induced strong immune responses following... 
Via Benzinga
Exposures COVID-19
AstraZeneca Kick-Starts New COVID-19 Variant Vaccine Trial
AstraZeneca Plc (NASDAQ: AZN) has started testing its new COVID vaccine, dubbed AZD2816, a tweaked version using the same platform as its authorized (though not in the... 
Via Benzinga
Exposures COVID-19
AstraZeneca's Nirsevimab Shows Favorable Safety, Tolerability Profile In Infants At High Risk Of RSV
AstraZeneca Plc (NASDAQ: AZN) announced data from the MEDLEY Phase 2/3 trial evaluating nirsevimab in infants at high risk of respiratory syncytial virus (RSV). The trial... 
Via Benzinga
Week In Review: Insilico Closes $255 Million Round For AI Drug Discovery/Development
Insilico Medicine, a Hong Kong company devoted to using AI to speed up drug discovery and R&D, closed a $255 million Series C round led by Warburg Pincus. The company is developing its own products and... 
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Summer Friday
The stock market tried for another record after yesterday's late blowout over the infrastructure deal. 
Via Talk Markets
AstraZeneca's Type 2 Diabetes Treatment Shows Clinical Benefit In Adolescents
AstraZeneca Plc (NASDAQ: AZN) has reported results from the Phase 3 trial evaluating exenatide extended-release 2mg in adolescents aged 10–17 years with type... 
Via Benzinga
Crazy Thursday
Today the US stock market went ballistic probably because of a higher joblessness level than expected. 
Via Talk Markets
New Cannabinoid-Based Drug Candidates from Artelo Biosciences Show Promise as Cancer and Mental Health Treatments; Key Data Due Before Year End
The following article is sponsored by the clinical communications unit of Redington, Inc. The information contained in this article in no way represents investment advice or... 
Via Benzinga
The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
Wednesday Is A Normal Day
Meme stocks Gamestop and Torchlight Energy both did share sales to cash in on their share price rises. 
Via Talk Markets
14 Biotech Stocks To Watch Over The Next 6 Months
Biotechs are at the mercy of several make-or-break catalysts that invariably have a big impact on stocks. A case in point was the strong upside in Biogen Inc.'s (NASDAQ:... 
Via Benzinga
How Pfizer and Moderna Could Profit Big-Time From AstraZeneca's and CureVac's Challenges
Bad news for AstraZeneca and CureVac should mean more good news for Pfizer and Moderna. 
Via The Motley Fool
Exposures COVID-19
AstraZeneca's Koselugo Gets European Nod To Treat Children With Multisystem Genetic Disorder
European Union has approved AstraZeneca plc's (NASDAQ: AZN) Koselugo to treat children with neurofibromatosis type 1 and plexiform neurofibromas. Neurofibromatosis... 
Via Benzinga
Dual-Antibody Cocktail Shows Effectiveness In COVID-19 Animal Models: Reuters
In mice and hamster study, COVID-19 therapies comprising two types of antibodies were found to be effective against a wide range of COVID-19 variants, Reuters reported ... 
Via Benzinga
Exposures COVID-19
< Previous 1 2
...
32 33 34 35 36 37 38 39 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.